Deep Track Capital

Venture capital firm

Portfolio

2 total

Attovia Therapeutics Triveni Bio

Co-Investors

12

EcoR1 Capital · 1 shared Frazier Life Sciences · 1 shared Goldman Sachs Alternatives · 1 shared Illumina Ventures · 1 shared Sanofi Ventures · 1 shared venBio Partners · 1 shared Ascenta Capital · 1 shared Atlas Venture · 1 shared Cormorant Asset Management · 1 shared Fidelity Management & Research · 1 shared Janus Henderson Investors · 1 shared OrbiMed · 1 shared

Latest Pulse

Pulse coverage →

Jul 29, 2026Goldman-Backed Attovia Seeks $212.5M in Biotech IPOAttovia Therapeutics is seeking up to $212.5 million in a US IPO, offering 12.5 million shares at $15-$17 each, backed by Goldman Sachs Alternatives, Deep Track Capital, Frazier Life Sciences, and venBio.→

Suggest a correction